Insights › Likitanci da magunguna › November 16, 2026
Likitanci da magunguna · Ayyukan da ake kan yi da ci gaba

IDEAYA Biosciences Ta Sanar da Nasarar Taron US FDA Type C Kan Tsarin Gwajin Rijista na Mataki na 2/3 don Goyon Bayan Yiwuwar Amincewa Mai Sauri da Cikakke don IDE849, Wani Mafi Kyawun DLL3 TOP1 ADC a Neuroendo

PR Newswire (Health) An wallafa: Regulatory

Kungiyar ƙarin gwaji ɗaya kusan marasa lafiya 90 na GEP-NEC don tallafawa yiwuwar amincewa mai sauri, tare da ORR ta BICR azaman babban maƙasudi Gwajin Mataki na 3 da aka tsara a cikin nau'ikan NEC marasa lafiya da yawa, gami da GEP-NEC da LC-NEC, an tsara shi don tallafawa cikakken amincewa,...

Asalin tushe
Karanta tushen — prnewswire.com ↗

Muna haɗawa da ainihin mai wallafawa. Taƙaitawar da ke sama jagora ce kawai; karanta asalin don cikakken bayani.

Ƙari a Likitanci da magunguna

Duba komai a cikin Likitanci da magunguna →

Ƙara bincika wannan batu

Karanta kowane bayani da yarenka

Wannan shafi yana nuna sabbin abubuwa uku ne kawai a kowane fanni. Mambobi na ganin kowane bayani a cikin fannin, a harsuna 109, tare da injinan bincike da ke aiki a kansu.

Karanta duka — fara daga $3Babu buƙatar shigarwa daga kantin manhajoji. Ana iya soke shi kowane lokaci.